PRACTICE POINTER Contraceptive and hormonal treatment options for women with history of venous thromboembolism

被引：13
|
作者：
Stam-Slob, Manon C. [1 ,3 ]
Lambalk, Cornelis B.
van de Ree, Marcel A. [2 ,4 ]
机构：
[1] Diakonessenhuis Utrecht, Dept Internal Med, NL-3508 TG Utrecht, Netherlands
[2] Diakonessenhuis Utrecht, Dept Internal Med, Internal & Vasc Med, NL-3508 TG Utrecht, Netherlands
[3] Univ Med Ctr Utrecht, Utrecht, Netherlands
[4] Vrije Univ Amsterdam Med Ctr, Dept Obstet & Gynecol, Gynaecol, NL-1007 MB Amsterdam, Netherlands
来源：
BMJ-BRITISH MEDICAL JOURNAL | 2015年 / 351卷
关键词：
ORAL-CONTRACEPTIVES; RISK; NORGESTIMATE; THROMBOSIS; ESTROGEN; THERAPY; EVENTS;
D O I：
10.1136/bmj.h4847
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
[No abstract available]
引用
收藏
页数：7
相关论文
共 47 条
  • [1] Venous thromboembolism in women using hormonal contraceptives
    Blanco-Molina, Angeles
    Trujillo-Santos, Javier
    Tirado, Raimundo
    Canas, Inmaculada
    Riera, Antoni
    Valdes, Mariano
    Monreal, Manuel
    THROMBOSIS AND HAEMOSTASIS, 2009, 101 (03) : 478 - 482
  • [2] First venous thromboembolism and hormonal contraceptives in young French women
    Hugon-Rodin, Justine
    Horellou, Marie-Helene
    Conard, Jacqueline
    Flaujac, Claire
    Gompel, Anne
    Plu-Bureau, Genevieve
    MEDICINE, 2017, 96 (34)
  • [3] Clinical profile and recurrence rate in women with venous thromboembolism during combined hormonal contraceptive use: a prospective cohort study
    van Vlijmen, Elizabeth F. W.
    Makelburg, Anja B. U.
    Knol, H. Marieke
    Tichelaar, Vladimir I. G. V.
    Kluin-Nelemans, Hanneke C.
    Veeger, Nic J. G. M.
    Meijer, Karina
    BRITISH JOURNAL OF HAEMATOLOGY, 2016, 172 (04) : 636 - 638
  • [4] Is family history sufficient to identify women with risk of venous thromboembolism before commencing the contraceptive pill?
    Aznar, J
    Mira, Y
    Vayá, A
    Ferrando, F
    Villa, P
    CLINICAL AND APPLIED THROMBOSIS-HEMOSTASIS, 2002, 8 (02) : 139 - 141
  • [5] Venous thromboembolism in women with hormone-dependent breast cancer. To continue or discontinue hormonal treatment? Insights from the RIETE registry
    Asin, Maria Asuncion Perez-Jacoiste
    Molina, Angeles Blanco
    Gomez-Cuervo, Covadonga
    Diaz-Pedroche, Maria del Carmen
    Pedrajas, Jose Maria
    Lopez-Nunez, Juan Jose
    Gil-Diaz, Aida
    Alda-Lozano, Alicia
    Bosevski, Marijan
    Monreal, Manuel
    THROMBOSIS RESEARCH, 2024, 241
  • [6] Plasma Fibrin Clot Properties Are Unfavorably Altered in Women following Venous Thromboembolism Associated with Combined Hormonal Contraception
    Pirog, Magdalena
    Piwowarczyk, Slawomir
    Undas, Anetta
    DISEASE MARKERS, 2019, 2019
  • [7] Hormonal contraceptive use after a first venous thrombotic event and the risk of recurrence in premenopausal women
    Verlaan, Judith P. L.
    Stegeman, Bernadine H.
    Timp, Jasmijn F.
    Scheres, Luuk J. J.
    Flinterman, Linda E.
    Helmerhorst, Frans M.
    Rosendaal, Frits R.
    Cannegieter, Suzanne C.
    Vlieg, Astrid van Hylckama
    JOURNAL OF THROMBOSIS AND HAEMOSTASIS, 2024, 22 (08) : 2195 - 2202
  • [8] Hormonal contraception, sickle cell trait, and risk for venous thromboembolism among African American women
    Austin, Harland
    Lally, Cathy
    Benson, Jane M.
    Whitsett, Carolyn
    Hooper, W. Craig
    Key, Nigel S.
    AMERICAN JOURNAL OF OBSTETRICS AND GYNECOLOGY, 2009, 200 (06) : 620.e1 - 620.e3
  • [9] Management of anticoagulation in pregnant women with venous thromboembolism: An international survey of clinical practice
    Simard, C.
    Malhame, I
    Skeith, L.
    Carson, M. P.
    Rey, E.
    Tagalakis, V
    THROMBOSIS RESEARCH, 2022, 210 : 20 - 25
  • [10] Venous thromboembolism in young women - Role of thrombophilic mutations and oral contraceptive use
    Legnani, C
    Palareti, G
    Guazzaloca, G
    Cosmi, B
    Lunghi, B
    Bernardi, F
    Coccheri, S
    EUROPEAN HEART JOURNAL, 2002, 23 (12) : 984 - 990
12345